Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Abemaciclib + Anastrozole & Breast Cancer / Mammacarcinoma (HR+ Her2-), the FDA has approved the use of abemaciclib in combination with an aromatase inhibitor (including Abemaciclib + Anastrozole) as an initial endocrine-based therapy for postmenopausal women with advanced or metastatic Breast Cancer / Mammacarcinoma (HR+ Her2-). This approval is based on the results of the MONARCH 3 trial. The trial specifically included letrozole or anastrozole as the [aromatase inhibitors](brain://e-jasjN-CUOzu3aRGdoIaA/Aromata…